Publication: Epigenetic approach to early-onset Parkinson's disease: Low methylation status of SNCA and PARK2 promoter regions
Date
Authors
Eryılmaz, Işıl Ezgi
Çeçener, Gulşah
Erer, Sevda
Egeli, Ünal
Tunca, Berrin
Zarifoğlu, Mehmet
Authors
Elibol, Bülent
Bora, Ayşe Tokcaer
Saka, Esen
Demirkıran, Meltem
Akbostancı, Cenk
Doğu, Okan
Çolakoğlu, Beril
Kenangil, Gülay
Kaleagası, Hakan
Advisor
Language
Type
Publisher:
Taylor & Francis
Journal Title
Journal ISSN
Volume Title
Abstract
Background and aim: The effect of epigenetic modifications in the genes related to Parkinson's disease (PD) is still unclear. In the present study, we investigated methylation status of SNCA and PARK2 genes in patients with early-onset Parkinson's disease (EOPD). Materials and methods: The promoter region methylation status of SNCA and PARK2 genes was evaluated by methylation specific-PCR (MSP) in 91 patients with EOPD and 52 healthy individuals. Results: The methylation of SNCA and PARK2 promoter regions were significantly lower in EOPD patients compared to the control group (P = 0.013 and P = 0.03, respectively). We also found that the methylation status of the SNCA might be associated with positive family history of PD (P = 0.042). Conclusion: Although it should be supported by further analysis, based on the results of the present study, the methylation status of SNCA and PARK2 genes might contribute to EOPD pathogenesis.
Description
Source:
Keywords:
Keywords
Neurosciences & neurology, Early-onset parkinson’s disease, Epigenetic, Methylation, PARK2, SNCA, Alpha-synuclein, Leukocyte dna, Gene, Mutations, Expression
Citation
Eryılmaz, I. E. vd. (2017). ''Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions''. Neurological Research, 39(11), 965-972.